India to focus on domestic vaccine demand; will not expand export for few months: Sources
India will focus on meeting the domestic demand for coronavirus vaccines in view of a spike in COVID-19 infections in several…
Author
Indian drug manufacturer sentenced to pay USD 50 million in fines
An Indian drug manufacturer has been sentenced to pay USD 50 million in fines and forfeiture after pleading guilty to concealing…
Cipla board approves reappointment of Umang Vohra as MD & Global CEO for 5 years
Cipla on Tuesday said its board has approved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the…
Glenmark gets USD 40 million COVID credit line from International Finance Corporation
IFC's partnership with Glenmark began way back in 2016, supporting its expansion and growing its research and development…
Oxford AstraZeneca jabs effective against severe COVID new trial in US confirms
A large trial in the US and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at…
Bhutan PM thanks Modi for gift of additional 4 00 000 doses of COVID-19 vaccine
Bhutan Prime Minister Lotay Tshering on Monday expressed gratitude to his Indian counterpart Narendra Modi for making the…
RDIF, Virchow Biotech sign agreement to produce 200 million doses of Sputnik V vaccine
The technology transfer is expected to be completed in the second quarter of 2021 followed by full-scale commercial production of…
8-10 months protection possible with COVID-19 vaccine: AIIMS director
He said the biggest reason for the surge in cases is that people feel the pandemic is over and they are not following…
Maha wants to manufacture Covaxin at Haffkine: Rajesh Tope
The state government is also ready if Bharat Biotech wants to produce Covaxin in Haffkine Institute, says Tope
India’s reputation as pharmacy of world reinforced: Jaishankar
Making a statement in the Rajya Sabha on ‘Vaccine Maitri’ initiative, he said that India has supplied 'Made-in-India' vaccine to…